journal article·2019-12-21Open access

Are Fe-Based Stenting Materials Biocompatible? A Critical Review of In Vitro and In Vivo Studies

Eleonora Scarcello, Dominique Lison

Abstract

Fe-based materials have increasingly been considered for the development of biodegradable cardiovascular stents. A wide range of in vitro and in vivo studies should be done to fully evaluate their biocompatibility. In this review, we summarized and analyzed the findings and the methodologies used to assess the biocompatibility of Fe materials. The majority of investigators drew conclusions about in vitro Fe toxicity based on indirect contact results. The setup applied in these tests seems to overlook the possible effects of Fe corrosion and does not allow for understanding of the complexity of released chemical forms and their possible impact on tissue. It is in particular important to ensure that test setups or interpretations of in vitro results do not hide some important mechanisms, leading to inappropriate subsequent in vivo experiments. On the other hand, the sample size of existing in vivo implantations is often limited, and effects such as local toxicity or endothelial function are not deeply scrutinized. The main advantages and limitations of in vitro design strategies applied in the development of Fe-based alloys and the correlation with in vivo studies are discussed. It is evident from this literature review that we are not yet ready to define an Fe-based material as safe or biocompatible.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Corrosion Behavior and Inhibition · Hydrogen embrittlement and corrosion behaviors in metals

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Louvain centre for Toxicology and Applied Pharmacology (LTAP), Université catholique de Louvain, 1200 Brussels, Belgium

Funding

Communauté française de Belgique. Sections de Recherche Concertées

References (74)

Show source-provided references
1. Biodegradable Metal Stents: A Focused Review on Materials and Clinical Studies10.1166/jbt.2014.1263 ↗
2. Short-term effects of biocorrodible iron stents in porcine coronary arteries10.1111/j.1540-8183.2007.00319.x ↗
3. Biodegradable Metals for Cardiovascular Stents: From Clinical Concerns to Recent Zn-Alloys10.1002/adhm.201501019 ↗
4. A simplified in vivo approach for evaluating the bioabsorbable behavior of candidate stent materials10.1002/jbm.b.31922 ↗
5. Boccaccini, Iron and iron-based alloys for temporary cardiovascular applications10.1007/s10856-015-5473-8 ↗
6. A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal—Results 6–18 months after implantation into New Zealand white rabbits
7. Biocompatibility of pure iron: In vitro assessment of degradation kinetics and cytotoxicity on endothelial cells10.1016/j.msec.2008.12.019 ↗
8. Design of a pseudo-physiological test bench specific to the development of biodegradable metallic biomaterials10.1016/j.actbio.2007.09.012 ↗
9. Degradation performance of biodegradable Fe-Mn-C(-Pd) alloys10.1016/j.msec.2012.10.013 ↗
10. Cardiovascular stents: Overview, evolution, and next generation10.1007/s40204-018-0097-y ↗
11. Iron metabolism and toxicity10.1016/j.taap.2004.06.021 ↗
12. Disorders of iron metabolism10.1056/NEJM199912233412607 ↗
13. Nordberg, G.F., Fowler, B.A., and Nordberg, M. (2015). Chapter 41—Iron, in Handbook on the Toxicology of Metals, Academic Press. [4th ed.].10.1016/B978-0-444-59453-2.00001-9 ↗
14. The heme oxygenase system: Past, present, and future
15. Molecular control of iron metabolism10.1016/j.beha.2004.10.004 ↗
16. Chemistry and biology of eukaryotic iron metabolism10.1016/S1357-2725(01)00063-2 ↗
17. Fenton- and Fenton-Like AOPs for Wastewater Treatment: From Laboratory-To-Plant-Scale Application10.1080/01496390701290151 ↗
18. On the cytocompatibility of biodegradable Fe-based alloys10.1016/j.msec.2012.11.002 ↗
19. Iron overload and its association with cancer risk in humans: Evidence for iron as a carcinogenic metal10.1016/j.mrfmmm.2003.08.023 ↗
20. The Development of Awareness of the Carcinogenic Hazard of Inhaled Iron
21. Physicochemical mechanism of the interaction between cobalt metal and carbide particles to generate toxic activated oxygen species10.1021/tx00046a015 ↗
22. Response of human endothelial cells to oxidative stress on Ti6Al4V alloy10.1016/j.biomaterials.2006.09.033 ↗
23. The role of oxidative stress in pro-inflammatory activation of human endothelial cells on Ti6Al4V alloy10.1016/j.biomaterials.2013.07.030 ↗
24. Advanced Oxidation Processes (AOPs) in Wastewater Treatment10.1007/s40726-015-0015-z ↗
25. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease10.1007/s11883-012-0266-8 ↗
26. There is no such thing as a biocompatible material10.1016/j.biomaterials.2014.08.035 ↗
27. Khan, W., Muntimadugu, E., Jaffe, M., and Domb, A.J. (2014). Domb, Implantable Medical Devices. Focal Controlled Drug Delivery, Springer.10.1007/978-1-4614-9434-8_2 ↗
28. A Review of the Biocompatibility of Implantable Devices: Current Challenges to Overcome Foreign Body Response10.1177/193229680800200610 ↗
29. ISO (2009). ISO 10993-5-2009 International Organisation for Standardization, International Organization for Standardization (ISO). [3rd ed.].
30. Assessing the biocompatibility of degradable metallic materials: State-of-the-art and focus on the potential of genetic regulation10.1016/j.actbio.2010.02.027 ↗
31. Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury
32. Cyclic chalcone analogue KRP6 as a potent modulator of cell proliferation: An in vitro study in HUVECs10.1007/s11033-013-2547-x ↗
33. The Role of MCPIP1 in Ischemia/Reperfusion Injury-Induced HUVEC Migration and Apoptosis10.1159/000430378 ↗
34. Control of smooth muscle cell proliferation by ferrous iron10.1016/j.biomaterials.2005.10.042 ↗
35. Cytotoxicity and its test methodology for a bioabsorbable nitrided iron stent10.1002/jbm.b.33246 ↗
36. Is there any difference in the biological impact of soluble and insoluble degradation products of iron-containing biomaterials?10.1016/j.colsurfb.2017.09.032 ↗
37. Hydroxyl radicals and oxidative stress: The dark side of Fe corrosion10.1016/j.colsurfb.2019.110542 ↗
38. Roughness statistical influence on cell adhesion using profilometry and multiscale analysis10.1002/sca.21061 ↗
39. On the relation between surface roughness of metallic substrates and adhesion of human primary bone cells10.1002/sca.21067 ↗
40. Gawlik, M.M., Wiese, B., Desharnais, V., Ebel, T., and Willumeit-Romer, R. (2018). The Effect of Surface Treatments on the Degradation of Biomedical Mg Alloys-A Review Paper. Materials (Basel), 11.10.3390/ma11122561 ↗
41. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63)10.1002/jbm.820290314 ↗
42. A review on in vitro corrosion performance test of biodegradable metallic materials10.1016/S1003-6326(13)62730-2 ↗
43. In vitro corrosion, cytotoxicity and hemocompatibility of bulk nanocrystalline pure iron10.1088/1748-6041/5/6/065015 ↗
44. In vitro investigation of Fe30Mn6Si shape memory alloy as potential biodegradable metallic material10.1016/j.matlet.2010.10.068 ↗
45. In vitro degradation and biocompatibility of Fe-Pd and Fe-Pt composites fabricated by spark plasma sintering10.1016/j.msec.2013.10.023 ↗
46. Oops They Did It Again! Carbon Nanotubes Hoax Scientists in Viability Assays10.1021/nl060177c ↗
47. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line10.1016/j.taap.2008.09.030 ↗
48. Interference of magnesium corrosion with tetrazolium-based cytotoxicity assays10.1016/j.actbio.2009.10.020 ↗
49. Oxidative stress in environmental-induced carcinogenesis10.1016/j.mrgentox.2008.09.017 ↗
50. Bioreactivity of Stent Material: In Vitro Impact of New Twinning-Induced Plasticity Steel on Platelet Activation10.4236/jbnb.2019.104010 ↗
51. Fe–Mn alloys for metallic biodegradable stents: Degradation and cell viability studies10.1016/j.actbio.2009.11.025 ↗
52. Atherosclerosis in the apolipoprotein-E-deficient mouse: A decade of progress10.1161/01.ATV.0000128849.12617.f4 ↗
53. Interactions between stainless steel, shear stress, and monocytes10.1002/jbm.a.31730 ↗
54. Electroformed pure iron as a new biomaterial for degradable stents: In vitro degradation and preliminary cell viability studies10.1016/j.actbio.2010.01.008 ↗
55. Biocorrosion properties and blood and cell compatibility of pure iron as a biodegradable biomaterial10.1007/s10856-010-4070-0 ↗
56. Comparative in vitro Study on Pure Metals (Fe, Mn, Mg, Zn and W) as Biodegradable Metals10.1016/j.jmst.2013.03.019 ↗
57. Gene expression profile of mouse fibroblasts exposed to a biodegradable iron alloy for stents10.1016/j.actbio.2013.02.033 ↗
58. In vitro and in vivo corrosion properties of new iron-manganese alloys designed for cardiovascular applications10.1002/jbm.b.33234 ↗
59. Long-term in vivo corrosion behavior, biocompatibility and bioresorption mechanism of a bioresorbable nitrided iron scaffold10.1016/j.actbio.2017.03.020 ↗
60. Ex vivo blood vessel bioreactor for analysis of the biodegradation of magnesium stent models with and without vessel wall integration10.1016/j.actbio.2016.12.039 ↗
61. Sex hormones and mucosal wound healing10.1016/j.bbi.2008.12.001 ↗
62. Gibney, E.R., Milenkovic, D., Combet, E., Ruskovska, T., Greyling, A., Gonzalez-Sarrias, A., de Roos, B., Tomas-Barberan, F., Morand, C., and Rodriguez-Mateos, A. (2019). Factors influencing the cardiometabolic response to (poly)phenols and phytosterols: A review of the COST Action POSITIVe activities. Eur. J. Nutr.10.1007/s00394-019-02066-6 ↗
63. Wnek, G.E., and Bowlin, G.L. (2004). Encyclopedia of Biomaterials and Biomedical Engineering, Marcel Dekker.
64. Neoatherosclerosis: Another Consequence of Endothelial Dysfunction?10.1161/CIRCINTERVENTIONS.114.001994 ↗
65. Angiogenic mechanisms of endothelialization of cardiovascular implants: A review of recent investigative strategies10.1163/156856200744200 ↗
66. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta10.1016/j.biomaterials.2006.05.029 ↗
67. Characterization and in vivo evaluation of a bio-corrodible nitrided iron stent10.1007/s10856-012-4823-z ↗
68. Short-term safety and efficacy of the biodegradable iron stent in mini-swine coronary arteries10.3760/cma.j.issn.0366-6999.20131120 ↗
69. Biodegradable Fe-based alloys for use in osteosynthesis: Outcome of an in vivo study after 52 weeks10.1016/j.actbio.2014.04.007 ↗
70. Binder-jetting 3D printing and alloy development of new biodegradable Fe-Mn-Ca/Mg alloys10.1016/j.actbio.2016.08.032 ↗
71. Are resorbable implants about to become a reality?10.1017/S1047951106000011 ↗
72. Biodegradable stents for coronary artery disease treatment: Recent advances and future perspectives10.1016/j.msec.2018.04.100 ↗
73. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries10.1002/ccd.20727 ↗
74. In vivo corrosion of four magnesium alloys and the associated bone response10.1016/j.biomaterials.2004.09.049 ↗